Regulation of human B lymphopoiesis by the transforming growth factor-β superfamily in a newly established coculture system using human mesenchymal stem cells as a supportive microenvironment

Experimental Hematology

Volumn 36, Issue 5, 2008, Pages 587-597

  Ichii, Michiko ^a   Oritani, Kenji ^a   Yokota, Takafumi ^a   Nishida, Makoto ^b   Takahashi, Isao ^a   Shirogane, Takahiro ^a   Ezoe, Sachiko ^a   Saitoh, Norimitsu ^a   Tanigawa, Rie ^a   Kincade, Paul W ^c   Kanakura, Yuzuru ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; ACTIVIN A ANTIBODY; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 4 ANTIBODY; CD34 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKINE ANTIBODY; FLT3 LIGAND; IMMUNOGLOBULIN M; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CD34 SELECTION; CELL COUNT; CELL MATURATION; COCULTURE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LYMPHOPOIESIS; MESENCHYMAL STEM CELL; MICROENVIRONMENT; MOUSE; MYELOPOIESIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; STROMA CELL; UMBILICAL CORD BLOOD;

ACTIVINS; ANTIBODIES; ANTIGENS, CD34; B-LYMPHOCYTES; COCULTURE TECHNIQUES; DRUG EVALUATION, PRECLINICAL; FLOW CYTOMETRY; HUMANS; LYMPHOPOIESIS; MESENCHYMAL STEM CELLS; MOLECULAR WEIGHT; NEPRILYSIN; RECOMBINANT PROTEINS; REFERENCE VALUES; TRANSFORMING GROWTH FACTOR BETA;

EID: 42249083035     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.12.013     Document Type: Article

References (41)

1. Kincade P.W., Oritani K., Zheng Z., Borghesi L., Smithson G., and Yamashita Y. Cell interaction molecules utilized in bone marrow. Cell Adhes Commun 6 (1998) 211-215
2. Miyake K., Medina K.L., Hayashi S., Ono S., Hamaoka T., and Kincade P.W. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med 171 (1990) 477-488
3. Miyake K., Weissman I.L., Greenberger J.S., and Kincade P.W. Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J Exp Med 173 (1991) 599-607
4. Oritani K., Medina K.L., Tomiyama Y., et al. Limitin: an interferon-like cytokine that preferentially influences B-lymphocyte precursors. Nat Med 6 (2000) 659-666
5. Oritani K., Hirota S., Nakagawa T., et al. T lymphocytes constitutively produce an interferon like cytokine limitin characterized as a heat- and acid-stable and heparin-binding glycoprotein. Blood 101 (2003) 178-185
6. Yokota T., Meka C.S.R., Kouro T., et al. Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells. J Immunol 171 (2003) 5091-5099
7. Fortunel N.O., Hatzfeld A., and Hatzfeld J.A. Transforming growth factor-β: pleiotropic role in the regulation of hematopoiesis. Blood 96 (2000) 2022-2036
8. van de Wetering M., de Lau W., and Clevers H. WNT signaling and lymphocyte development. Cell 109 (2002) S13-S19
9. Jaleco A.C., Neves H., Hooijberg E., et al. Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation. J Exp Med 194 (2001) 991-1001
10. Kouro T., Medina K.L., Oritani K., and Kincade P.W. Characteristics of early murine B-lymphocyte precursors and their direct sensitivity to negative regulators. Blood 97 (2001) 2708-2715
11. Borge O.J., Adolfsson J., and Jacobsen A.M. Lymphoid-restricted development from multipotent candidate murine stem cells: distinct and complimentary functions of the c-kit and flt3-ligands. Blood 94 (2000) 3781-3790
12. Nishihara M., Wada Y., Ogami K., et al. A combination of stem cell factor and granulocyte colony-stimulating factor enhances the growth of human progenitor B cells supported by murine stromal cell line MS-5. Eur J Immunol 28 (1998) 855-864
13. Rossi M.I.D., Yokota T., Medina K.L., et al. B lymphopoiesis is active throughout human life, but there are developmental age-related changes. Blood 101 (2003) 576-584
14. Hao Q.L., Zhu J., Price M.A., Payne K.J., Barsky L.W., and Crooks G.M. Identification of a novel, human multilymphoid progenitor in cord blood. Blood 97 (2001) 3683-3690
15. Miller J.S., McCullar V., Punzel M., Lemischka I.R., and Moore K.A. Single adult human CD34+/Lin-/CD38- progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells. Blood 93 (1999) 96-106
16. Goodwin R.G., Lupton S., Schmierer A., et al. Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl Acad Sci U S A 86 (1989) 302-306
17. Peschon J.J., Morrissey P.J., Grabstein K.H., et al. Early lymphocyte expansion is severely impaired in interleukin-7 receptor-deficient mice. J Exp Med 180 (1994) 1955-1960
18. von Freeden-Jeffrey U., Vieira P., Lucian L.A., McNeil T., Burdach S.E., and Muray R. Lymphopenia in interlekin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 181 (1995) 1519-1526
19. Puel A., Ziegler S.F., Buckley R.H., and Leonard W.J. Defective IL7R expression in T-B+NK+ severe combined immunodeficiency. Nat Genet 20 (1998) 394-397
20. Buckley R.H. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 22 (2004) 625-655
21. Pribyl J.A.R., and LeBien T.W. Interleukin 7 independent development of human B cells. Proc Natl Acad Sci U S A 93 (1996) 10348-10353
22. Dittel B.N., and LeBien T.W. The growth response to IL-7 during normal human B cell ontogeny is restricted to B-lineage cells expressing CD34. J Immunol 154 (1995) 58-67
23. Miyazawa K., Shinozaki M., Hara T., Furuya T., and Miyazono K. Two major Smad pathways in TGF-beta superfamily signaling. Genes Cells 7 (2002) 1191-1204
24. Shi Y., and Massague J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113 (2003) 685-700
25. Blobe G.C., Schiemann W.P., and Lodish H.F. Role of transforming growth factor-β in human disease. N Engl J Med 342 (2000) 1350-1358
26. Shav-Tal Y., and Zipori D. The role of Activin A in regulation of hemopoiesis. Stem Cells 20 (2002) 493-500
27. Bhatia M., Bonnet D., Wu D., et al. Bone morphogenetic proteins regulate the developmental program on human hematopoietic stem cells. J Exp Med 7 (1999) 1139-1147
28. Bertrand F.E., Vogtenhuber C., Shah N., and LeBien T.W. Pro-B cell to pre-B cell development in B-lineage acute lymphoblastic leukemia expressing the MLL/AF4 fusion protein. Blood 98 (2001) 3398-3405
29. Masaie H., Oritani K., Yokota T., et al. Adiponectin binds to chemokines via the globular head and modulates interactions between chemokines and heparan sulfates. Exp Hematol 35 (2007) 947-956
30. Yoshida H., Tomiyama Y., Oritani K., et al. Interaction between Src homology 2 domain bearing protein tyrosine phosphatase substrate-1 and CD47 mediates the adhesion of human B lymphocytes to nonactivated endothelial cells. J Immunol 168 (2002) 3213-3220
31. Majumdar M.K., Thiede M.A., Mosca J.D., Moorman M., and Gerson S.L. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 176 (1998) 57-66
32. Kim D.W., Chung Y.J., Kim T.G., Kim Y.L., and Oh I.H. Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood 103 (2004) 1941-1948
33. Nakata S., Matsumura I., Tanaka H., et al. NK-κB family proteins participate in multiple steps of hematopoesis through elimination of reactive oxygen species. J Biol Chem 279 (2004) 55578-55586
34. Sato N., Meijer L., Skaltsounis L., Greengard P., and Brivanlou A.H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 10 (2004) 55-63
35. Yaswen L., Kulkarni A.B., Fredrickson T., et al. Autoimmune manifestations in the transforming growth factor-beta 1 knock-out mouse. Blood 87 (1996) 1439-1445
36. Larsson J., Blank U., Helgadottir H., et al. TGF-β signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro. Blood 102 (2003) 3129-3135
37. Cazac B.B., and Roes J. TGF-β receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 13 (2000) 443-451
38. Kamesaki K., Nishizawa K., Michaud G.Y., Cossman J., and Kiyono T. TGF-β1 induces the cyclin-dependent kinase inhibitor p27kip1 mRNA and protein in murine B cells. J Immunol 160 (1998) 770-777
39. Kee B.L., Rivera R.R., and Murre C. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-β. Nat Immunol 2 (2001) 242-247
40. Lee G., Namen A.E., Gillis S., Ellingsworth L.R., and Kincade P.W. Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-β. J Immunol 142 (1989) 3875-3883
41. Zipori D., and Barda-Saad M. Role of activin A in negative regulation of normal and tumor B lymphocytes. J Leukoc Biol 69 (2001) 867-873